Camptosar
Showing 1 - 25 of 251
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)
Not yet recruiting
- Metastatic Solid Tumor
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 12, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)
Active, not recruiting
- GastroEsophageal Cancer
- Irinotecan
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2022
High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) Trial in San Francisco, Boston, New York (Pembrolizumab, Irinotecan,
Completed
- High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
- Pembrolizumab
- +2 more
-
San Francisco, California
- +2 more
Dec 5, 2022
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
-
Columbus, OhioNationwide Children's Hospital
Oct 26, 2022
Pancreatic Cancer Trial in Milwaukee (First-line Chemotherapy, Second-line Chemotherapy, Chemoradiation)
Recruiting
- Pancreatic Cancer
- First-line Chemotherapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 29, 2022
Adenocarcinoma, Pancreatic Tumors, Tumor, Glandular Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Capecitabine)
Recruiting
- Adenocarcinoma
- +9 more
- Nab-paclitaxel
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Mar 15, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- CPI 613
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022
Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)
Active, not recruiting
- Metastatic Colorectal Cancer
- CMAB009
- +3 more
-
Beijing, Beijing, China
- +1 more
Oct 18, 2022
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)
Recruiting
- Colon Adenocarcinoma
- Colorectal Cancer
- TAS-102
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
May 24, 2022
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)
Not yet recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
- Mycophenolate Mofetil
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
May 17, 2022
Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)
Terminated
- Metastatic Colorectal Cancer (CRC)
- BI 1701963
- Camptosar®
-
Shanghai, ChinaShanghai East Hospital, Tongji University China
Apr 19, 2022
Solid Tumor Malignancy Trial in Hackensack (Selinexor, Irinotecan)
Withdrawn
- Solid Tumor Malignancy
-
Hackensack, New JerseyJohn Theurer Cancer Center at HackensackUMC
Dec 14, 2021
Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)
Not yet recruiting
- Childhood CNS Tumor
- SGT-53
- +4 more
-
Washington, District of ColumbiaChildren's National Medical Center
Feb 7, 2022
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
- (no location specified)
May 5, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)
Active, not recruiting
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
-
Orange, California
- +1 more
Apr 4, 2022